Association between family history of dementia and hallucinations in Parkinson disease

Neurology. 2005 May 24;64(10):1712-5. doi: 10.1212/01.WNL.0000161872.85903.8E.

Abstract

Objective: To identify familial risk factors for hallucinations in patients with Parkinson disease (PD).

Methods: Two hundred seventy-six outpatients with PD participated in the study. The presence of hallucinations was determined using a validated questionnaire, including items regarding the occurrence of visual, auditory, or other types of hallucinations. Family history of PD and dementia was determined by a structured interview and examination of medical records and affected family members. Patients with young-onset PD (<50 years) who reported another PD patient among their siblings were tested for parkin mutations. Stepwise logistic regression was applied for the detection of risk factors. The regression model included a set of family history-related variables (family history of PD and of dementia) and a set of disease-related variables (age, age at onset of PD, stage, duration of PD and of l-dopa therapy, l-dopa dose, and number of antiparkinsonian drugs).

Results: Hallucinations were present in 32% of the 276 patients. Risk factors for hallucinations included Mini-Mental State Examination score (p < 0.0001) and positive family history of dementia (p = 0.0005).

Conclusion: Family history of dementia and lower Mini-Mental State Examination scores are risk factors for hallucinations in Parkinson disease.

MeSH terms

  • Age Factors
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Cross-Sectional Studies
  • DNA Mutational Analysis
  • Dementia / epidemiology*
  • Dementia / genetics*
  • Female
  • Genetic Testing
  • Hallucinations / epidemiology*
  • Hallucinations / genetics*
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Parkinson Disease / complications
  • Parkinson Disease / epidemiology*
  • Parkinson Disease / genetics*
  • Prevalence
  • Risk Factors
  • Surveys and Questionnaires
  • Ubiquitin-Protein Ligases / genetics

Substances

  • Levodopa
  • Ubiquitin-Protein Ligases
  • parkin protein